Institute Curie, France
Elderly women with breast cancer respond favorably to aromatase inhibitors
Published in Medicine and Law Weekly, October 13th, 2006
According to a recent report, "In France, 20% of breast cancers occur in women over the age of 70 and 10% in women over the age of 80. As these women are not included in screening programs, breast cancer is often diagnosed later, at the stage of a large tumor." Scientists at the Institut Curie sought "to analyze clinical response, possibilities of conservative treatment and course of hormonal receptors in patients receiving neoadjuvant aromatase inhibitor (AI) therapy for at least 6 months."
R.J. Salmon and colleagues explained, "There were 75...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly
More Articles from Medicine and Law Weekly
- Acacia Research
Acacia Technologies acquires rights to patents for medical image stabilization technology - Advanced Cell Technology
Advanced Cell Technology announces settlement of patent interference action - Amphora Discovery
Amphora Discovery forms two market-driven business units - AngioDynamics
AngioDynamics comments on judgment decision by court - Aomori Municipal Hospital, Aomori, Japan
Findings from Japan, the United States and the South Korea advance knowledge in angiology research - Barr Pharmaceuticals
Barr files an amended tender offer for Pliva - More from this issue of Medicine and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
